Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...

During monsoon season, respiratory infections, allergies, and chronic respiratory disorders including asthma and chronic ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase ...

Air quality reached "unhealthy" levels in parts of western Maine on Saturday after a plume of smoke moved in overnight.

At 12:40 p.m. Thursday, the National Weather Service issued the alert for Midland, Bay, Saginaw, Huron, Tuscola and Sanilac ...

Anoro Ellipta is a brand-name prescription medication to manage chronic obstructive pulmonary disease (COPD) symptoms in adults. Common side effects of Anoro Ellipta are generally mild, but ...

The Cambridge, England-based pharmaceutical company said the positive opinion from the Committee for Medicinal Products for Human Use endorses Trixeo Aerosphere, or ...

Basel: Roche has announced topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) ...

Some of the most interesting data are precisely those illustrating the reality of clinical practice of physicians attending ...